Intrinsic and extrinsic apoptosis responses in leukaemia cells following daunorubicin treatment
Abstract Background Daunorubicin is used clinically in the treatment of myeloma, acute lymphatic and myelocytic leukaemia. The toxic lesions caused by daunorubicin induce various modes of cell death, including apoptosis. Apoptosis is highly regulated programmed cell death that can be initiated mainl...
Main Authors: | Hussain Mubarak Al-Aamri, Helen R. Irving, Christopher Bradley, Terri Meehan-Andrews |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-04-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-021-08167-y |
Similar Items
-
Determination of the DNA repair pathways utilised by acute lymphoblastic leukaemia cells following daunorubicin treatment
by: Hussain Mubarak Al-Aamri, et al.
Published: (2019-09-01) -
Daunorubicin and Its Active Metabolite Pharmacokinetic Profiles in Acute Myeloid Leukaemia Patients: A Pharmacokinetic Ancillary Study of the BIG-1 Trial
by: Guillaume Drevin, et al.
Published: (2022-04-01) -
Oxaliplatin combined with daunorubicin induces apoptosis of colon cancer cell line HT-29
by: TIAN Chun-yang, LIU Xiao-zheng, FAN Jun-chao
Published: (2020-03-01) -
Olaparib Synergizes the Anticancer Activity of Daunorubicin via Interaction with AKR1C3
by: Tássia S. Tavares, et al.
Published: (2020-10-01) -
Effects of Royal Jelly on Apoptosis and the Expression of Apoptotic Genes on Testicular Tissue in Male Balb/C Mice Treated with Daunorubicin
by: Mansour Safaei Pourzamani, et al.
Published: (2023-05-01)